Creative Planning - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 118 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
Creative Planning ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$75,000
+25.0%
51,511
+21.2%
0.00%
Q4 2016$60,000
-23.1%
42,506
-5.0%
0.00%
Q3 2016$78,000
+5.4%
44,740
+2.8%
0.00%
-100.0%
Q2 2016$74,000
-7.5%
43,540
+7.1%
0.00%0.0%
Q1 2016$80,000
+12.7%
40,640
+9.4%
0.00%0.0%
Q4 2015$71,000
-12.3%
37,140
-12.2%
0.00%0.0%
Q3 2015$81,000
-63.2%
42,290
-10.9%
0.00%
-50.0%
Q2 2015$220,000
+14.0%
47,465
+7.4%
0.00%0.0%
Q1 2015$193,000
+49.6%
44,190
+18.8%
0.00%
+100.0%
Q4 2014$129,000
-22.3%
37,190
-6.0%
0.00%
-50.0%
Q3 2014$166,000
-33.1%
39,545
-6.7%
0.00%
-33.3%
Q2 2014$248,000
+26.5%
42,395
+36.3%
0.00%0.0%
Q1 2014$196,000
+79.8%
31,095
+66.6%
0.00%
+50.0%
Q4 2013$109,000
+153.5%
18,670
+127.7%
0.00%
+100.0%
Q3 2013$43,000
-27.1%
8,200
+6.5%
0.00%0.0%
Q2 2013$59,0007,7000.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 867,700$5,085,0001.68%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,369,066$25,603,0001.03%
Lyons Wealth Management, LLC. 56,775$334,0000.30%
Callan Capital, LLC 66,118$387,0000.10%
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC 383,050$2,245,0000.06%
FCG ADVISORS, LLC 10,600$62,0000.05%
OppenheimerFunds, Inc. 7,000,000$41,020,0000.04%
NEXT Financial Group, Inc 19,704$86,0000.04%
WELLINGTON MANAGEMENT GROUP LLP 27,893,387$163,455,0000.04%
MURPHY CAPITAL MANAGEMENT INC 45,000$263,0000.04%
View complete list of ARENA PHARMACEUTICALS INC shareholders